Insider Transactions in Q3 2024 at Phoenix Biotech Acquisition Corp. (PBAXU)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 25
2024
|
Stuart M Sloan > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
532,486
-2.47%
|
$0
$0.1 P/Share
|
|
Sep 25
2024
|
Brian G Atwood Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
19,358,578
+49.68%
|
-
|
|
Sep 25
2024
|
Christopher B Ehrlich Interim Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,312,983
+47.84%
|
-
|
|
Sep 25
2024
|
Kathleen Laporte Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
965,997
+50.0%
|
-
|